# Kaysersberg Pharmaceuticals SAS, Kaysersberg, France – FDA Inspections

Source: https://www.keypedia.com/companies/kaysersberg-pharmaceuticals-sas/4f0bba88-dadd-49db-8e17-08165e705377

> Inspection records and compliance data for Kaysersberg Pharmaceuticals SAS in Kaysersberg. 5 FDA inspections on record, 1 Form 483, last inspected May 17, 2024.

---

## Details

- Name: Kaysersberg Pharmaceuticals SAS
- FEI Number: 3002806288
- Business Operations: FDF MANUFACTURE
- Address Line 1: 23 avenue Georges Ferrenbach
- City: Kaysersberg
- Country Name: France
- Address: 23 avenue Georges Ferrenbach, Kaysersberg, France
- Country: France

## Related Documents

- FDA Inspection 1268813 - Kaysersberg Pharmaceuticals SAS - 2024-05-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2024
- [483 - Kaysersberg Pharmaceuticals SAS - 2023-07-07](https://www.keypedia.com/records/483/kaysersberg-pharmaceuticals-sas/7ea9666e-82c7-40b1-a9c0-03ebefaa7e8e) — source: FDA, date: July 7, 2023
- [FDA Inspection 1211467 - Kaysersberg Pharmaceuticals SAS - 2023-07-07](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/62c64822-d91d-4b24-a2f5-63f126424340) — source: FDA, date: July 7, 2023
- FDA Inspection 1123773 - Kaysersberg Pharmaceuticals SAS - 2019-02-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2019
- [483 - Kaysersberg Pharmaceuticals SAS - 2016-07-19](https://www.keypedia.com/records/483/kaysersberg-pharmaceuticals-sas/0c0bf131-b1c2-42bc-9baa-13273ff535d0) — source: FDA, date: July 19, 2016
- [FDA Inspection 981303 - Kaysersberg Pharmaceuticals SAS - 2016-07-19](https://www.keypedia.com/records/fda_inspections/kaysersberg-pharmaceuticals-sas/107d2a0c-87ae-4a0f-95a0-14a5eb7bcbc2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2016
- FDA Inspection 661210 - Kaysersberg Pharmaceuticals SAS - 2010-04-19 — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2010

## Related Companies

- [ENDO Pharmaceuticals Solutions, Inc.](https://www.keypedia.com/companies/endo-pharmaceuticals-solutions-inc/73c5da1a-04ad-4b56-9fae-f0a1371df51f)
- [Steriscience Specialties Private Limited](https://www.keypedia.com/companies/steriscience-specialties-private-limited/f2814c8b-daff-42a4-abe2-59947a5bda3d)
- [Baxter Pharmaceuticals India Pvt Ltd](https://www.keypedia.com/companies/baxter-pharmaceuticals-india-pvt-ltd/dc51d849-2ff2-4ad0-bb54-cb013fd2e24d)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/977203cc-5cbe-49ea-9b42-0b797ade4b5e)
- [Steriscience SP. Z O.O.](https://www.keypedia.com/companies/steriscience-sp-z-oo/a2c32aee-8f5f-4bd3-8cc9-9fdcf970ebf4)
- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)](https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/02eeb237-fdd8-40a0-b45c-d4d88f49eb6c)
- [Ningbo Shuangcheng Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/ningbo-shuangcheng-pharmaceutical-co-ltd/942c1651-ee36-4163-9687-ca694ddc24d2)
- [Baxter SA](https://www.keypedia.com/companies/baxter-sa/4cc540bc-58e1-460a-be6e-c6c8c7d2ee47)
- [Lyocontract GmbH](https://www.keypedia.com/companies/lyocontract-gmbh/0c56698a-6a88-4c94-9de9-6e9f5172cf27)
- [Baxter Healthcare Pty Ltd](https://www.keypedia.com/companies/baxter-healthcare-pty-ltd/a37e00b9-5cbd-4f45-922b-0f352f015507)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-a-charles/f83241f0-ae3b-4535-ac03-e790bbf666ca)
- [Lori B. Wikstrom](https://www.keypedia.com/people/lori-b-wikstrom/19d938f7-4a5d-42b9-b2d1-e92cdb63bb0d)
